ReviewTrends in molecular medicine2020

Accelerated Approval or Risk Reduction? How Response Biomarkers Advance Therapeutics through Clinical Trials in Cystic Fibrosis.

N Mayer-Hamblett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.